Trial · NCT03493945
Participant flow56
How many started, completed or left each group, period by period.
1 to 20 of 56
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Phase I Dose Escalation | STARTED | Phase (Ph) I Dose Escalation, Cohort 1, Arm 1.1, Dose Level (DL) 1 | 4 | |
| Phase I Dose Escalation | STARTED | Phase I Dose Escalation, Cohort 1, Arm 1.1 Dose Level 2 | 10 | |
| Phase I Dose Escalation | STARTED | Phase I Dose Escalation, Cohort 1: Enrolled But Not Treated | 1 | |
| Phase I Dose Escalation | STARTED | Phase IIA Dose Expansion (Dose Exp.), Cohort 2, Arm 2.1A | 0 | |
| Phase I Dose Escalation | STARTED | Phase IIA Dose Expansion, Cohort 2, Arm 2.2A | 0 | |
| Phase I Dose Escalation | STARTED | Phase IIB, Dose Expansion, Cohort 2, Arm 2.2B | 0 | |
| Phase I Dose Escalation | STARTED | Phase IIA Dose Expansion, Cohort 2A, Arm 2.3A | 0 | |
| Phase I Dose Escalation | COMPLETED | Phase (Ph) I Dose Escalation, Cohort 1, Arm 1.1, Dose Level (DL) 1 | 4 | |
| Phase I Dose Escalation | COMPLETED | Phase I Dose Escalation, Cohort 1, Arm 1.1 Dose Level 2 | 9 | |
| Phase I Dose Escalation | COMPLETED | Phase I Dose Escalation, Cohort 1: Enrolled But Not Treated | 0 | |
| Phase I Dose Escalation | COMPLETED | Phase IIA Dose Expansion (Dose Exp.), Cohort 2, Arm 2.1A | 0 | |
| Phase I Dose Escalation | COMPLETED | Phase IIA Dose Expansion, Cohort 2, Arm 2.2A | 0 | |
| Phase I Dose Escalation | COMPLETED | Phase IIB, Dose Expansion, Cohort 2, Arm 2.2B | 0 | |
| Phase I Dose Escalation | COMPLETED | Phase IIA Dose Expansion, Cohort 2A, Arm 2.3A | 0 | |
| Phase I Dose Escalation | NOT COMPLETED | Phase (Ph) I Dose Escalation, Cohort 1, Arm 1.1, Dose Level (DL) 1 | 0 | |
| Phase I Dose Escalation | NOT COMPLETED | Phase I Dose Escalation, Cohort 1, Arm 1.1 Dose Level 2 | 1 | |
| Phase I Dose Escalation | NOT COMPLETED | Phase I Dose Escalation, Cohort 1: Enrolled But Not Treated | 1 | |
| Phase I Dose Escalation | NOT COMPLETED | Phase IIA Dose Expansion (Dose Exp.), Cohort 2, Arm 2.1A | 0 | |
| Phase I Dose Escalation | NOT COMPLETED | Phase IIA Dose Expansion, Cohort 2, Arm 2.2A | 0 | |
| Phase I Dose Escalation | NOT COMPLETED | Phase IIB, Dose Expansion, Cohort 2, Arm 2.2B | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03493945/flow